|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.47 USD | +16.86% |
|
+10.22% | +14.11% |
| 07-17 | Xencor's Cancer Drug Study Selected for Oral Presentation at ESMO; Shares Rise | MT |
| 05-13 | Xencor, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:00 PM |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XENCOR, INC. | Bio Therapeutic Drugs | +16.86% | +10.22% | +14.11% | +92.61% | -47.24% | 1.3B |  | | |
- Stock Market
- Stocks
- XNCR Stock
- Charts Xencor, Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
